Why Is Processa Therapeutics (PCSA) Stock Up 90% Today?

Clinical-stage pharmaceutical company Processa Therapeutics (NASDAQ:PCSA) — which specializes in the field of oncology — is skyrocketing on Thursday. PCSA stock is up about 90% as of this writing, although shares climbed more than 150% at one point today. Undergirding sentiment are encouraging…

#processatherapeutics #ngccap #phase2 #fda #scientifically #grandviewresearch #maximgroups #nazrahman #pennystocks #joshenomoto